Article Information
History
- January 18, 2023.
Article Versions
- Version 1 (December 18, 2022 - 23:11).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Caroline Fairhurst1,
- Fabiola Martin2,
- Ian Watt1,
- Martin Bland1,
- Tim Doran1 and
- William J. Brackenbury3,*
- 1Department of Health Sciences, University of York, UK
- 2School of Public Health, University of Queensland, Australia
- 3York Biomedical Research Institute, Department of Biology, University of York, UK
- ↵*Corresponding author: William J. Brackenbury, York Biomedical Research Institute, Department of Biology, University of York, Heslington, York, YO10 5DD, UK, E-mail: william.brackenbury{at}york.ac.uk Telephone: +44 (0) 1904 328 284
Posted January 18, 2023.
Sodium channel-inhibiting drugs and cancer-specific survival: a population-based study of electronic primary care data
